Leadership Overview
Clario has 8 executives leading key functions including strategy, operations, revenue, medical oversight, and information technology.
Focused on advancing clinical trial technology, Clario delivers comprehensive endpoint solutions that empower pharmaceutical and medical device partners to generate high-quality evidence across global decentralized and hybrid research models.
Focused on advancing clinical trial technology, Clario delivers comprehensive endpoint solutions that empower pharmaceutical and medical device partners to generate high-quality evidence across global decentralized and hybrid research models.
Leadership Roles at Clario
Joshua Collins - Chief Executive Officer & Founder
Joshua Collins, the Chief Executive Officer & Founder at Clario, directs the overarching corporate strategy and long-term vision for the organization. By aligning scientific expertise with advanced endpoint technology, the Chief Executive Officer & Founder ensures that pharmaceutical and biotechnology partners receive the necessary tools to transform patient lives. Joshua Collins maintains a focus on scaling the Trial Anywhere approach to support complex clinical trials across North America, Europe, and the Asia Pacific region. This leadership role involves constant collaboration with the Board to drive innovation in decentralized and hybrid trial models. Through the integration of global operational standards, the Chief Executive Officer & Founder secures the company's position as a leader in clinical evidence generation. By prioritizing regulatory excellence and technological advancement, the executive fosters a culture of precision that supports the entire clinical research ecosystem.
Nayan Nanavati - Chief Operating Officer
Nayan Nanavati, the Chief Operating Officer at Clario, manages the internal scaling and operational efficiency of the company's global technology platform. Overseeing the execution of clinical trial workflows, the Chief Operating Officer ensures that internal processes remain agile enough to support diverse site-based and decentralized research models. Nayan Nanavati drives the optimization of resource allocation across international markets, ensuring that technical teams maintain high-quality standards for endpoint data collection. This role requires close coordination with technology departments to refine the platform's capabilities for medical device partners. By streamlining operational delivery, the Chief Operating Officer directly impacts the speed and accuracy of regulatory approvals for clients. Through rigorous process management, the executive maintains the operational integrity required to support large-scale clinical trials, ultimately facilitating the seamless delivery of critical evidence to global pharmaceutical organizations.
Angelo Stortini - Chief Operating Officer & Senior VP
Angelo Stortini, the Chief Operating Officer & Senior VP at Clario, focuses on supply chain logistics and the physical infrastructure supporting clinical trial endpoint technology. By managing the deployment of hardware and diagnostic tools, the Chief Operating Officer & Senior VP ensures that site-based trials receive consistent, high-quality equipment across all operational regions. Angelo Stortini architects the logistical frameworks that allow for the rapid distribution of technology in hybrid trial environments. This leadership position involves mitigating risks within the global supply chain to prevent disruptions in data collection for biotechnology partners. Through the oversight of procurement and distribution networks, the executive guarantees that the company's technological assets remain available for critical research. By enhancing the reliability of physical trial infrastructure, the Chief Operating Officer & Senior VP supports the broader mission of generating robust clinical evidence for medical device and pharmaceutical clients.
Charles Bodner - Executive Vice President & Chief Operating Officer
Charles Bodner, the Executive Vice President & Chief Operating Officer at Clario, oversees the integration of cross-functional teams to ensure the seamless delivery of clinical trial services. By directing the operational strategy for decentralized trial models, the Executive Vice President & Chief Operating Officer ensures that technology and science teams work in unison to meet regulatory requirements. Charles Bodner manages the implementation of large-scale projects, ensuring that global operations remain compliant with international standards. This leadership role involves optimizing the interface between the company's technology platform and the specific needs of medical device partners. Through the continuous improvement of service delivery models, the executive enhances the efficiency of clinical evidence generation. By fostering collaboration across departments, the Executive Vice President & Chief Operating Officer drives the operational excellence necessary to support the company's mission of transforming lives through high-quality clinical data.
Matthew Borer - Senior Commercial Director - Strategic Chief Revenue Officer Partnerships
Matthew Borer, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships at Clario, drives revenue growth through the cultivation of high-value alliances with global pharmaceutical and biotechnology firms. By identifying market opportunities for the company's endpoint technology platform, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships expands the reach of the Trial Anywhere approach. Matthew Borer manages complex contract negotiations and ensures that commercial strategies align with the evolving needs of clinical research partners. This role involves coordinating with internal teams to tailor service offerings for specific therapeutic areas, thereby maximizing market penetration across North America and international territories. Through the development of strategic partnerships, the executive secures long-term financial stability and supports the company's growth objectives. By focusing on client-centric solutions, the Senior Commercial Director - Strategic Chief Revenue Officer Partnerships ensures that the organization remains the preferred partner for clinical evidence generation.
Todd Rudo - Chief Medical Officer
Todd Rudo, the Chief Medical Officer at Clario, provides the scientific leadership necessary to validate the company's endpoint technology solutions. By overseeing the medical integrity of clinical trial data, the Chief Medical Officer ensures that all evidence generated meets the rigorous standards required for regulatory approvals. Todd Rudo directs the scientific strategy, guiding the development of tools that accurately capture patient outcomes in both site-based and decentralized environments. This role involves advising pharmaceutical and biotechnology partners on the best clinical practices for utilizing the company's platform. Through the application of deep medical expertise, the executive ensures that the technology remains at the forefront of clinical research innovation. By maintaining high scientific standards, the Chief Medical Officer supports the company's commitment to delivering reliable evidence that facilitates the development of life-changing medical treatments and devices for patients worldwide.

Fabian Chen - Vice President and Deputy Chief Medical Officer, Cardiology
Fabian Chen, the Vice President and Deputy Chief Medical Officer, Cardiology at Clario, specializes in the application of cardiac safety and efficacy metrics within clinical trials. By providing expert guidance on cardiovascular endpoint technology, the Vice President and Deputy Chief Medical Officer, Cardiology ensures that trials involving heart-related treatments generate precise and actionable data. Fabian Chen directs the scientific approach for cardiac-focused research, helping biotechnology partners navigate complex regulatory landscapes. This role involves collaborating with the broader medical team to integrate specialized cardiology insights into the company's global platform. Through the development of advanced diagnostic protocols, the executive enhances the quality of evidence for medical device and pharmaceutical clients. By focusing on the specific needs of cardiac research, the Vice President and Deputy Chief Medical Officer, Cardiology supports the company's mission to deliver high-quality clinical evidence that improves patient outcomes in the cardiovascular space.
Gary Zimmer - Information
Gary Zimmer, the Information at Clario, manages the digital infrastructure and data security protocols essential for clinical trial operations. By architecting secure cloud environments, the Information ensures that sensitive patient data remains protected while remaining accessible for analysis across global research sites. Gary Zimmer drives the implementation of advanced data management systems that support the company's endpoint technology platform. This leadership role involves coordinating with technology teams to maintain high uptime and system reliability for pharmaceutical partners. Through the oversight of cybersecurity initiatives, the executive mitigates risks associated with digital clinical evidence collection. By ensuring the robustness of the company's information systems, the Information supports the seamless execution of hybrid and decentralized trials. Through constant innovation in data architecture, the executive maintains the technological foundation required for the company to deliver high-quality clinical evidence to the global market.
Explore Leadership Teams in Business Services
Avanade is a global professional services and technology consulting company specializing in Microsoft-based digital and business solutions. It helps organizations modernize operations through cloud computing, artificial intelligence, data analytics, cybersecurity, enterprise applications, and software development. The company combines technology expertise with industry knowledge to improve business performance, enhance customer experiences, and accelerate digital transformation across various industries.
Company Leadership GR
AK
JJ
AS
Presidio is a global digital services and technology solutions provider that helps organizations modernize, secure, and transform their IT environments. Its services span AI, cloud, networking, cybersecurity, data platforms, application modernization, managed services, digital workplace solutions, and technology procurement.
Company Leadership

BL
RJ
Xoriant, a premier Software Engineering and Digital IT services provider with Fortune 100 customers worldwide, today announced its acquisition by ChrysCapital. This marks a brand-new phase of growth for Xoriant with its rich culture of innovation, global presence, and more than 30 years of passion, purpose, and progress. ChrysCapital is a leading private equity firm with a successful track record of investing in Business Services (IT/Engineering/Business Process), Financial Services, Pharma and Consumer-focused companies. This is the second buyout from ChrysCapital' s ninth fund and its ninth Business Services buyout since inception.
Company Leadership AA

RA

8x8 offers a unified cloud communication platform designed for enterprises, providing solutions such as call center services, phone systems, and video conferencing. Their products include 8x8 Work for voice and video communication, 8x8 Contact Center for enhanced customer experiences, and 8x8 AI Studio for building AI agents. Targeting industries like retail, healthcare, and finance, 8x8 aims to optimize workforce engagement and elevate customer support. The company also supports partners in delivering modern communication solutions without significant costs.
Company Leadership

